[
    [
        {
            "time": "",
            "original_text": "智飞生物(300122.SZ)：股东吴冠江减持期届满累计减持2956.85万股 减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "股东减持",
                    "吴冠江",
                    "减持计划"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)：股东吴冠江减持期届满累计减持2956.85万股 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：吴冠江累计减持1.85%股份，减持计划届满 拟减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "减持计划",
                    "累计减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物：吴冠江累计减持1.85%股份，减持计划届满 拟减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：板块整体回调 季报期关注业绩确定性",
            "features": {
                "keywords": [
                    "医药生物",
                    "板块回调",
                    "季报期",
                    "业绩确定性"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：板块整体回调 季报期关注业绩确定性",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "晨会纪要2020年第187期",
            "features": {
                "keywords": [
                    "晨会纪要",
                    "2020年",
                    "第187期"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会纪要2020年第187期",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 3,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "生物医药行业深度报告：疫情、医保、集采 影响终端销售的三个关键词",
            "features": {
                "keywords": [
                    "生物医药",
                    "疫情",
                    "医保",
                    "集采",
                    "终端销售"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "生物医药行业深度报告：疫情、医保、集采 影响终端销售的三个关键词",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]